Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer

ConclusionThese findings suggest that plasma THBS1 may be serving as an unfavorable prognosis predictor for HER2-enriched breast cancer and justifies the need for further research.

http://rd.springer.com/10.1007/s10147-024-02472-9

Source: International Journal of Clinical Oncology - February 27, 2024 Category: Cancer & Oncology Source Type: research